Medizinische Hochschule Hannover (MHH) / Hannover Medical School
University / College
Location:
Hannover,
Germany (DE)
ISNI: 0000000095299877
ROR: https://ror.org/00f2yqf98
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass) (2023)
Grünwald V, Ivanyi P, Zschäbitz S, Wirth M, Staib P, Schostak M, Dargatz P, et al.
Journal article
Vaccine Development during a Pandemic: General Lessons for Clinical Trial Design (2023)
Hofner B, Asikanius E, Jacquet W, Framke T, Oude Rengerink K, Aguirre Dávila L, Grünewald M, et al.
Journal article
Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data (2023)
Birkner T, Siegels D, Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder I, et al.
Journal article
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel (2023)
Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, et al.
Journal article
Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples (2023)
Maier EM, Mütze U, Janzen N, Steuerwald U, Nennstiel U, Odenwald B, Schuhmann E, et al.
Journal article
Pediatric multi-drug-resistant tuberculosis in Germany – diagnostic and therapeutic challenges of an “orphan disease” (2023)
Schäfer HL, Barker M, Follmann P, Günther A, Hörning A, Kaiser-Labusch P, Kerzel S, et al.
Journal article
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. (2023)
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, et al.
Journal article
Fetal Assessment in Pregnancy (Indication and Methodology for Fetal Monitoring in a low-risk Population). Guideline of the DGGG, DEGUM, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/089, February 2023) (2023)
Schiermeier S, Von Kaisenberg CS, Kehl S, Reister F, Mosimann B, Reif P, Harlfinger W, et al.
Journal article
Investigation of OCTA Biomarkers in Fabry Disease: A Long Term Follow-Up of Macular Vessel Area Density and Foveal Avascular Zone Metrics (2023)
Hufendiek K, Lindziute M, Kaufeld J, Volkmann I, Brockmann D, Hosari S, Hohberger B, et al.
Journal article
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma (2023)
Mikuteit M, Zschäbitz S, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al.
Journal article